PMID- 27701480 OWN - NLM STAT- MEDLINE DCOM- 20171218 LR - 20181113 IS - 1680-0745 (Electronic) IS - 1995-1892 (Print) IS - 1015-9657 (Linking) VI - 28 IP - 2 DP - 2017 Mar/Apr 23 TI - Factors associated with early mortality in haemodialysis patients undergoing coronary artery bypass surgery. PG - 108-111 LID - 10.5830/CVJA-2016-066 [doi] AB - INTRODUCTION: Coronary artery bypass grafting (CABG) results in higher morbidity and mortality rates in end-stage renal disease (ESRD) patient populations than in patients with normal renal function. This study aimed to identify the early results of CABG performed on ESRD patients, and the factors that affected the mortality rates of those patients. METHODS: A retrospective evaluation of our hospital database revealed 84 haemodialysis-receiving patients who underwent CABG during the years 2006 to 2012. Mortality was observed in 21 patients (group 1), and this group was compared with the remaining patients (group 2) for peri-operative parameters such as age, EuroSCORE, functional capacity, myocardial infarction, use of inotropes and completeness of revascularisation. RESULTS: The study included 60 male (71.4%) and 24 female patients (28.6%); the participants' mean age was 59.50 +/- 9.93 years. The pre-operative additive EuroSCORE was 7.96 +/- 2.88 (range: 2-18). Pre-operative functional capacity was impaired in 35.7% of the patients [New York Heart Association (NYHA) classes III-IV]. Mean age and preoperative EuroSCORE values of group 1 were significantly higher than those of group 2. Impaired functional capacity (NHYA classes III-IV) was also associated with mortality (OR: 3.333; 95% CI: 1.199-9.268). Fifty-four patients (64.3%) underwent on-pump CABG procedures, and 30 (35.7%) underwent off-pump CABG procedures. The study found no statistically significant difference in mortality rates between these two techniques. Mortality occurred in 12 patients (22.2%) in the on-pump group and in nine (30%) in the off-pump group. Complete revascularisation was performed on 46 patients (85.2%) in the on-pump group and seven (23.3%) in the off-pump group (p < 0.001). CONCLUSION: Advanced age, impaired NYHA functional capacity and pre-operative hypertension were determinative for early-term surgical mortality. An on-pump surgical technique is recommended to ensure completeness of revascularisation. FAU - Cevirme, Deniz AU - Cevirme D AD - Department of Cardiovascular Surgery, Kartal Kosuyolu Heart and Research Hospital, Istanbul, Turkey. FAU - Adademir, Taylan AU - Adademir T AD - Department of Cardiovascular Surgery, Kartal Kosuyolu Heart and Research Hospital, Istanbul, Turkey. Email: taylanadademir@gmail.com. FAU - Aksut, Mehmet AU - Aksut M AD - Department of Cardiovascular Surgery, Kartal Kosuyolu Heart and Research Hospital, Istanbul, Turkey. FAU - Orki, Tulay AU - Orki T AD - Department of Anesthesiology, Kartal Kosuyolu Heart and Research Hospital, Istanbul, Turkey. FAU - Cakalagaoglu, Kamil Canturk AU - Cakalagaoglu KC AD - Department of Cardiovascular Surgery, Kartal Kosuyolu Heart and Research Hospital, Istanbul, Turkey. FAU - Alp, Mete AU - Alp M AD - Department of Cardiovascular Surgery, Kartal Kosuyolu Heart and Research Hospital, Istanbul, Turkey. FAU - Kirali, Kaan AU - Kirali K AD - Department of Cardiovascular Surgery, Kartal Kosuyolu Heart and Research Hospital, Istanbul, Turkey. LA - eng PT - Journal Article DEP - 20160722 PL - South Africa TA - Cardiovasc J Afr JT - Cardiovascular journal of Africa JID - 101313864 SB - IM MH - Age Factors MH - Aged MH - Cardiopulmonary Bypass/adverse effects/mortality MH - Chi-Square Distribution MH - Coronary Artery Bypass/adverse effects/*mortality MH - Coronary Artery Bypass, Off-Pump/adverse effects/mortality MH - Coronary Artery Disease/diagnosis/mortality/*surgery MH - Databases, Factual MH - Female MH - Humans MH - Hypertension/mortality MH - Kidney Failure, Chronic/diagnosis/mortality/*therapy MH - Male MH - Middle Aged MH - Multivariate Analysis MH - Odds Ratio MH - Patient Selection MH - Renal Dialysis/adverse effects/*mortality MH - Retrospective Studies MH - Risk Assessment MH - Risk Factors MH - Time Factors MH - Treatment Outcome PMC - PMC5488051 EDAT- 2016/10/05 06:00 MHDA- 2017/12/19 06:00 PMCR- 2017/03/01 CRDT- 2016/10/05 06:00 PHST- 2015/12/07 00:00 [received] PHST- 2016/05/29 00:00 [accepted] PHST- 2016/10/05 06:00 [pubmed] PHST- 2017/12/19 06:00 [medline] PHST- 2016/10/05 06:00 [entrez] PHST- 2017/03/01 00:00 [pmc-release] AID - 10.5830/CVJA-2016-066 [doi] PST - ppublish SO - Cardiovasc J Afr. 2017 Mar/Apr 23;28(2):108-111. doi: 10.5830/CVJA-2016-066. Epub 2016 Jul 22.